Related references
Note: Only part of the references are listed.A pilot study of urinary microRNA as a biomarker for urothelial cancer
Jaime Snowdon et al.
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL (2013)
Individual risk assessment in bladder cancer patients based on a multi-marker panel
Tilman Todenhoefer et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Plasma microRNA profiles for bladder cancer detection
Liana Adam et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
miR-143, miR-222, and miR-452 Are Useful as Tumor Stratification and Noninvasive Diagnostic Biomarkers for Bladder Cancer
Patricia Puerta-Gil et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
NMR-based Metabolomic Analysis of Human Bladder Cancer
Ming Cao et al.
ANALYTICAL SCIENCES (2012)
Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis
P. Gazzaniga et al.
ANNALS OF ONCOLOGY (2012)
Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study
Severine Huber et al.
BJU INTERNATIONAL (2012)
An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer
S. Miah et al.
BRITISH JOURNAL OF CANCER (2012)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria
Funso Abogunrin et al.
CANCER (2012)
A Candidate Molecular Biomarker Panel for the Detection of Bladder Cancer
Virginia Urquidi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Molecular Diagnostic Trends in Urological Cancer: Biomarkers for Non-Invasive Diagnosis
V. Urquidi et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Prognostic Role and HER2 Expression of Circulating Tumor Cells in Peripheral Blood of Patients Prior to Radical Cystectomy: A Prospective Study
Michael Rink et al.
EUROPEAN UROLOGY (2012)
Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer
Tibor Szarvas et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Comparative and Targeted Proteomic Analyses of Urinary Microparticles from Bladder Cancer and Hernia Patients
Chien-Lun Chen et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Influence of Renal Excretory Function on the Performance of Urine Based Markers to Detect Bladder Cancer
Tilman Todenhoefer et al.
JOURNAL OF UROLOGY (2012)
Diagnostic Potential of Urinary α1-Antitrypsin and Apolipoprotein E in the Detection of Bladder Cancer
Virginia Urquidi et al.
JOURNAL OF UROLOGY (2012)
The Emerging Role of Circulating Tumor Cell Detection in Genitourinary Cancer
Alexander C. Small et al.
JOURNAL OF UROLOGY (2012)
Detecting DNA Methylation of the BCL2, CDKN2A and NID2 Genes in Urine Using a Nested Methylation Specific Polymerase Chain Reaction Assay to Predict Bladder Cancer
Michael B. Scher et al.
JOURNAL OF UROLOGY (2012)
A Multigene Urine Test for the Detection and Stratification of Bladder Cancer in Patients Presenting with Hematuria
Paul O'Sullivan et al.
JOURNAL OF UROLOGY (2012)
CCL18 in a Multiplex Urine-Based Assay for the Detection of Bladder Cancer
Virginia Urquidi et al.
PLOS ONE (2012)
Bladder Cancer Diagnosis and Identification of Clinically Significant Disease by Combined Urinary Detection of Mcm5 and Nuclear Matrix Protein 22
John D. Kelly et al.
PLOS ONE (2012)
A Multi-Analyte Assay for the Non-Invasive Detection of Bladder Cancer
Steve Goodison et al.
PLOS ONE (2012)
Urinary BTA: indicator of bladder cancer or of hematuria
Makito Miyake et al.
WORLD JOURNAL OF UROLOGY (2012)
Influencing factors on the NMP-22 urine assay: an experimental model
Makito Miyake et al.
BMC UROLOGY (2012)
Methylation Markers for Urine-Based Detection of Bladder Cancer: The Next Generation of Urinary Markers for Diagnosis and Surveillance of Bladder Cancer
Thomas Reinert
ADVANCES IN UROLOGY (2012)
Combining cytology, TRAP assay, and FISH analysis for the detection of bladder cancer in symptomatic patients
S. Bravaccini et al.
ANNALS OF ONCOLOGY (2011)
Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer
Michael Rink et al.
BJU INTERNATIONAL (2011)
Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysis
Pavlos Msaouel et al.
BMC CANCER (2011)
Detection of Bladder Cancer Using Novel DNA Methylation Biomarkers in Urine Sediments
Woonbok Chung et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Metabolomic Profiling Reveals Potential Markers and Bioprocesses Altered in Bladder Cancer Progression
Nagireddy Putluri et al.
CANCER RESEARCH (2011)
MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology
Yasutoshi Yamada et al.
CANCER SCIENCE (2011)
Urinary Glycoprotein Biomarker Discovery for Bladder Cancer Detection Using LC/MS-MS and Label-Free Quantification
Na Yang et al.
CLINICAL CANCER RESEARCH (2011)
The prognostic value of hematological and systemic inflammatory disorders in invasive bladder cancer
Georgios Gakis et al.
CURRENT OPINION IN UROLOGY (2011)
TCF21 and PCDH17 methylation An innovative panel of biomarkers for a simultaneous detection of urological cancers
Vera L. Costa et al.
EPIGENETICS (2011)
Stress Proteins and Cytokines are Urinary Biomarkers for Diagnosis and Staging of Bladder Cancer
David Margel et al.
EUROPEAN UROLOGY (2011)
Urine Markers for Detection and Surveillance of Non-Muscle-Invasive Bladder Cancer
Derya Tilki et al.
EUROPEAN UROLOGY (2011)
MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review
James W. F. Catto et al.
EUROPEAN UROLOGY (2011)
Prospective Multi-Institutional Study Evaluating the Performance of Prostate Cancer Risk Calculators
Robert K. Nam et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Optimization of Nonmuscle Invasive Bladder Cancer Recurrence Detection Using a Urine Based FGFR3 Mutation Assay
Tahlita C. M. Zuiverloon et al.
JOURNAL OF UROLOGY (2011)
MicroRNA Expression Signatures of Bladder Cancer Revealed by Deep Sequencing
Yonghua Han et al.
PLOS ONE (2011)
Clinical Usefulness of CEA, CA19-9, and CYFRA 21-1 as Tumor Markers for Urothelial Bladder Carcinoma
Satoshi Washino et al.
UROLOGIA INTERNATIONALIS (2011)
Metabolomics and bladder cancer
Matthew E. Hyndman et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2011)
Detection of Circulating Tumor Cells in Metastatic and Clinically Localized Urothelial Carcinoma
Thomas W. Flaig et al.
UROLOGY (2011)
Point-of-Care Tests for Bladder Cancer: The Influencing Role of Hematuria
Joerg Hennenlotter et al.
ADVANCES IN UROLOGY (2011)
Multicolor FISH (UroVysion) Facilitates Follow-up of Patients With High-Grade Urothelial Carcinoma of the Bladder
Hans-Martin Fritsche et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
Prognostic significance of survivin-expressing circulating tumour cells in T1G3 bladder cancer
Angela Gradilone et al.
BJU INTERNATIONAL (2010)
A Multiplexed, Particle-Based Flow Cytometric Assay Identified Plasma Matrix Metalloproteinase-7 to Be Associated With Cancer-Related Death Among Patients With Bladder Cancer
Robert S. Svatek et al.
CANCER (2010)
Fluorescence In Situ Hybridization for Detecting Urothelial Carcinoma A Clinicopathologic Study
Nancy P. Caraway et al.
CANCER CYTOPATHOLOGY (2010)
Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer
Tibor Szarvas et al.
CANCER SCIENCE (2010)
Fibroblast Growth Factor Receptor 3 Mutation Analysis on Voided Urine for Surveillance of Patients with Low-Grade Non-Muscle-Invasive Bladder Cancer
Tahlita C. M. Zuiverloon et al.
CLINICAL CANCER RESEARCH (2010)
Gene Expression Signature in Urine for Diagnosing and Assessing Aggressiveness of Bladder Urothelial Carcinoma
Lourdes Mengual et al.
CLINICAL CANCER RESEARCH (2010)
CEACAM1: A Novel Urinary Marker for Bladder Cancer Detection
Derya Tilki et al.
EUROPEAN UROLOGY (2010)
Tissue and serum proteomic profiling for diagnostic and prognostic bladder cancer biomarkers
Kristina Schwamborn et al.
EXPERT REVIEW OF PROTEOMICS (2010)
Local-Learning-Based Feature Selection for High-Dimensional Data Analysis
Yijun Sun et al.
IEEE TRANSACTIONS ON PATTERN ANALYSIS AND MACHINE INTELLIGENCE (2010)
Noninvasive Urinary Metabonomic Diagnosis of Human Bladder Cancer
Kishore Kumar Pasikanti et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Discovery of Novel Bladder Cancer Biomarkers by Comparative Urine Proteomics Using iTRAQ Technology
Yi-Ting Chen et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Expression of HYAL1 and Survivin RNA as Diagnostic Molecular Markers for Bladder Cancer
Sanaa Eissa et al.
JOURNAL OF UROLOGY (2010)
FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy
Lucie C. Kompier et al.
PLOS ONE (2010)
Are nomograms needed in the management of bladder cancer?
Carvell T. Nguyen et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer
Merle Hanke et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
Enrichment of Glycoproteins using Nanoscale Chelating Concanavalin A Monolithic Capillary Chromatography
Shun Feng et al.
ANALYTICAL CHEMISTRY (2009)
Detection of circulating tumor cells in patients with urothelial cancer
D. J. Gallagher et al.
ANNALS OF ONCOLOGY (2009)
Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract
Veronique Phe et al.
BJU INTERNATIONAL (2009)
Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection
Yair Lotan et al.
BJU INTERNATIONAL (2009)
Bladder Cancer-Associated Gene Expression Signatures Identified by Profiling of Exfoliated Urothelia
Charles J. Rosser et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
Lars Dyrskjot et al.
CANCER RESEARCH (2009)
Cystatin B As a Tissue and Urinary Biomarker of Bladder Cancer Recurrence and Disease Progression
Adam S. Feldman et al.
CLINICAL CANCER RESEARCH (2009)
Serum Proteomic Profiling in Patients with Bladder Cancer
Kristina Schwamborn et al.
EUROPEAN UROLOGY (2009)
Microsatellite Analysis of Voided-Urine Samples for Surveillance of Low-Grade Non-Muscle-Invasive Urothelial Carcinoma: Feasibility and Clinical Utility in a Prospective Multicenter Study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer Trial [CEFUB])
Madelon N. M. van der Aa et al.
EUROPEAN UROLOGY (2009)
Identification and Validation of the Methylated TWIST1 and NID2 Genes through Real-Time Methylation-Specific Polymerase Chain Reaction Assays for the Noninvasive Detection of Primary Bladder Cancer in Urine Samples
Isabelle Renard et al.
EUROPEAN UROLOGY (2009)
Optimizing Molecular Signatures for Predicting Prostate Cancer Recurrence
Yijun Sun et al.
PROSTATE (2009)
Combinations of urine-based tumour markers in bladder cancer surveillance
Marcus Horstmann et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2009)
Commentary: the role of cytologic analysis of voided urine in the work-up of asymptomatic microhematuria
Deep Trivedi et al.
BMC Urology (2009)
Utility of serial urinary cytology in the initial evaluation of the patient with microscopic hematuria
Kogenta Nakamura et al.
BMC Urology (2009)
A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis
Morgan Roupret et al.
BJU INTERNATIONAL (2008)
Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder
Andrew Holyoake et al.
CLINICAL CANCER RESEARCH (2008)
Quantitation of aurora kinase A gene copy number in urine sediments and bladder cancer detection
Hong-Seok Park et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry
Haleem J. Issaq et al.
JOURNAL OF UROLOGY (2008)
Low Circulating Levels of ProMMP-2 Are Associated with Adverse Prognosis in Bladder Cancer
Kaija Vasala et al.
TUMOR BIOLOGY (2008)
The value of combined use of survivin, cytokeratin 20 and mucin 7 mRNA for bladder cancer detection in voided urine
Xiao-Yong Pu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology
Michal Daniely et al.
CANCER CYTOPATHOLOGY (2007)
Detailed technical analysis of urine RNA-based tumor diagnostics reveals ETS2/urokinase plasminogen activator to be a novel marker for bladder cancer
Merle Hanke et al.
CLINICAL CHEMISTRY (2007)
Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach
Esteban Orenes-Pinero et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer
Anne B. Als et al.
CLINICAL CANCER RESEARCH (2007)
Gene expression signatures predict outcome in non-muscle invasive bladder carcinoma:: A multicenter validation study
Lars Dyrskjot et al.
CLINICAL CANCER RESEARCH (2007)
Urinary cytokeratin 20 mRNA expression has the potential to predict recurrence in superficial transitional cell carcinoma of the bladder
Frank Christoph et al.
CANCER LETTERS (2007)
Improved breast cancer prognosis through the combination of clinical and genetic markers
Yijun Sun et al.
BIOINFORMATICS (2007)
Detection of bladder cancer from the urine using fluorescence in situ hybridization technique
Peter Riesz et al.
PATHOLOGY & ONCOLOGY RESEARCH (2007)
Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection
Mohammad Obaidul Hoque et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria
MF Sarosdy et al.
JOURNAL OF UROLOGY (2006)
uCyt+ test: Alternative to cystoscopy for less-invasive follow-up of patients with low risk of urothelial carcinoma
Michele Lodde et al.
UROLOGY (2006)
Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder
PI Karakiewicz et al.
BJU INTERNATIONAL (2006)
Discovery and validation of new protein biomarkers for 4 urothelial cancer: a prospective analysis
D Theodorescu et al.
LANCET ONCOLOGY (2006)
Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer
A Kumar et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2006)
Overexpression of α-defensin is associated with bladder cancer invasiveness
DA Holterman et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2006)
uCyt+/ImmunoCyt™ in the detection of recurrent urothelial carcinoma -: An update on 1991 analyses
C Mian et al.
CANCER CYTOPATHOLOGY (2006)
Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays
M Sanchez-Carbayo et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Surveillance for recurrent bladder cancer using a point-of-care proteomic assay
HB Grossman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Fluorescence in situ hybridization for detecting transitional cell carcinoma:: implications for clinical practice
J Laudadio et al.
BJU INTERNATIONAL (2005)
Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors
K Zieger et al.
CLINICAL CANCER RESEARCH (2005)
A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine
JMM van Oers et al.
CLINICAL CANCER RESEARCH (2005)
Proteome analysis of gelatin-bound urinary proteins from patients with bladder cancers
M Saito et al.
EUROPEAN UROLOGY (2005)
Stage-dependent increase of orosomucoid and zinc-alpha2-glycoprotein in urinary bladder cancer
S Irmak et al.
PROTEOMICS (2005)
Relevance of urine telomerase in the diagnosis of bladder cancer
MA Sanchini et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Performance of urine test in patients monitored for recurrence of bladder cancer: A multicenter study in the United States
EM Messing et al.
JOURNAL OF UROLOGY (2005)
Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis
S Weikert et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Bladder cancer outcome and subtype classification by gene expression
E Blaveri et al.
CLINICAL CANCER RESEARCH (2005)
Urine markers for bladder cancer surveillance: A systematic review
BWG van Rhijn et al.
EUROPEAN UROLOGY (2005)
Detection of bladder cancer using a point-of-care proteomic assay
HB Grossman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
ImmunoCyt/uCyt plus (TM) improves the sensitivity of urine cytology in patients followed for urothelial carcinoma
B Tetu et al.
MODERN PATHOLOGY (2005)
Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel
E Dulaimi et al.
CLINICAL CANCER RESEARCH (2004)
Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: A side-by-side comparison
S Hautmann et al.
EUROPEAN UROLOGY (2004)
Evaluation of nuclear matrix protein-22 as a clinical diagnostic marker for bladder cancer
YH Chang et al.
UROLOGY (2004)
Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients
MG Friedrich et al.
CLINICAL CANCER RESEARCH (2004)
Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer
MG Friedrich et al.
BJU INTERNATIONAL (2003)
Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder
SF Shariat et al.
UROLOGY (2003)
Preoperative plasma soluble E-cadherin predicts metastases to lymph nodes and prognosis in patients undergoing radical cystectomy
K Matsumoto et al.
JOURNAL OF UROLOGY (2003)
Measurements of complement factor H-related protein (BTA-TRAK (TM) assay) and nuclear matrix protein (NMP22 assay) - Useful diagnostic tools in the diagnosis of urinary bladder cancer?
B Mahnert et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2003)
A comparison of BTA stat, hemoglobin dipstick, telomerase and vysis urovysion assays for the detection of urothelial carcinoma in urine
KC Halling et al.
JOURNAL OF UROLOGY (2002)
False-positive results of the NMP22 test due to hematuria
N Atsü et al.
JOURNAL OF UROLOGY (2002)
Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis
MP Raitanen et al.
EUROPEAN UROLOGY (2002)
Serum DNA and urine DNA alterations of urinary transitional cell bladder carcinoma detected by fluorescent microsatellite analysis
R von Knobloch et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Screening and monitoring for bladder cancer: Refining the use of NMP22
LE Ponsky et al.
JOURNAL OF UROLOGY (2001)
Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine
A Vlahou et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Usefulness of the BTA stat Test for the diagnosis of bladder cancer
JLG Baños et al.
UROLOGY (2001)
A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma
KC Halling et al.
JOURNAL OF UROLOGY (2000)
Urinary hyaluronic acid and hyaluronidase: Markers for bladder cancer detection and evaluation of grade
VB Lokeshwar et al.
JOURNAL OF UROLOGY (2000)
Primary superficial bladder cancer risk groups according to progression, mortality and recurrence
F Millan-Rodriguez et al.
JOURNAL OF UROLOGY (2000)
Share Paper
